F013 Approach to Melanoma Diagnosis
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Transitioning to a more patient-centered approach to melanoma detection requires a critical understanding of the current knowledge and issues surrounding the epidemiology of melanoma, precursors of melanoma, and clinical and histologic diagnosis of melanoma as they are related to limitations of the diagnostic gold standard, under- and over diagnosis of melanoma, and advances in molecular diagnostics. Faculty members will present data and analysis of their respective expertise, providing strategies for more optimal patient-centered management of melanocytic lesions. The session is geared toward all levels of trainees and practicing clinicians.
LEARNING OBJECTIVES
Evaluate the current trends in the epidemiology of melanoma
Recognize the various diagnostic issues of melanoma
Summarize the strategies to achieve a patient-centered approach to melanoma detection
SCHEDULE
6:00 PM
Melanoma epidemic: real or imaginary?
Chauncey A McHargue, MD, FAAD
6:20 PM
Current trends in melanoma epidemiology
Neda Nikbakht, MD, PhD, FAAD
6:30 PM
Clinical Approach To Melanoma Detection
Jason Bok Lee, MD, FAAD
6:45 PM
Melanoma: Advances in Diagnostics
Daniel F Lozeau, MD, FAAD
7:00 PM
Scope and harm of melanoma overdiagnosis
Adewole Shomari Adamson, MD, MPP, FAAD
7:20 PM
Dealing with melanoma overdiagnosis- Can we find an off-ramp?
Robert Swerlick, MD, FAAD
7:45 PM
Q&A
SPEAKERS
Adewole Shomari Adamson, MD, MPP, FAAD
Jason Bok Lee, MD, FAAD
Daniel F Lozeau, MD, FAAD
Chauncey A McHargue, MD, FAAD
Neda Nikbakht, MD, PhD, FAAD
Robert Swerlick, MD, FAAD
SPEAKER DISCLOSURES
Adewole Shomari Adamson, MD, MPP, FAAD
No financial relationships exist with ineligible companies.
Jason Bok Lee, MD, FAAD
No financial relationships exist with ineligible companies.
Daniel F Lozeau, MD, FAAD
No financial relationships exist with ineligible companies.
Chauncey A McHargue, MD, FAAD
No financial relationships exist with ineligible companies.
Neda Nikbakht, MD, PhD, FAAD
Helsinn Healthcare – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Krystal Biotech, Inc – Advisory Board(Honoraria); Kyowa Kirin – Advisory Board(Honoraria);
Robert Swerlick, MD, FAAD
No financial relationships exist with ineligible companies.